California State Teachers Retirement System Purchases 9,988 Shares of Maximus, Inc. $MMS

California State Teachers Retirement System grew its holdings in Maximus, Inc. (NYSE:MMS) by 18.8% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 63,142 shares of the health services provider’s stock after buying an additional 9,988 shares during the quarter. California State Teachers Retirement System owned approximately 0.12% of Maximus worth $4,047,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the company. Farther Finance Advisors LLC boosted its stake in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Advisory Services Network LLC bought a new stake in Maximus during the third quarter worth about $32,000. Canada Pension Plan Investment Board bought a new position in shares of Maximus in the 2nd quarter valued at about $35,000. Northwestern Mutual Wealth Management Co. boosted its position in Maximus by 225.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after purchasing an additional 304 shares during the period. Finally, Richardson Financial Services Inc. boosted its holdings in shares of Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after buying an additional 103 shares during the period. Institutional investors own 97.21% of the company’s stock.

Key Stories Impacting Maximus

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Fiscal Q3 adjusted earnings were $2.22 per share, ahead of analyst estimates of approximately $2.20–$2.21 and up from $2.16 a year earlier. Higher margins also supported the quarter’s bottom-line performance. Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
• Positive Sentiment: The earnings beat, year-over-year EPS growth and stronger margins indicate that Maximus is maintaining profitability even as sales soften. Maximus Q3 Earnings Beat Estimates
• Neutral Sentiment: Management’s fiscal Q3 earnings call focused on the quarterly performance and updated outlook, providing investors with additional context on operating trends and the company’s expectations for the remainder of fiscal 2026. Maximus Q3 2026 Earnings Call Transcript
• Negative Sentiment: Revenue was $1.28 billion, below the $1.33 billion consensus estimate and down 5.1% year over year. The shortfall suggests softer demand or project timing is limiting growth. Maximus Fiscal Q3 Earnings Snapshot
• Negative Sentiment: Maximus reduced fiscal 2026 EPS guidance to $7.90–$8.20, below the consensus estimate of $8.43. Revenue guidance of $5.2–$5.4 billion remains broadly in line with expectations at the midpoint, but the lower profit outlook is a key overhang for MMS. Updated Maximus Fiscal 2026 Guidance

Maximus Price Performance

MMS stock opened at $59.21 on Friday. The firm has a 50-day moving average of $58.63 and a 200 day moving average of $67.46. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.21. The company has a market cap of $3.11 billion, a P/E ratio of 8.75 and a beta of 0.59. Maximus, Inc. has a 1 year low of $52.73 and a 1 year high of $100.00.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating the consensus estimate of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the firm posted $2.16 earnings per share. The company’s revenue for the quarter was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 8.05 EPS for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, August 14th. Maximus’s dividend payout ratio is presently 19.76%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on MMS shares. Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.